Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Annexin Pharmaceuticals AB (publ)

Closing information (x1000 EUR)

Closing information 2022/12 2021/12 2020/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 More Arrow 182 Less Arrow 50
Earnings before taxes -3,660 Less Arrow -5,099 More Arrow -4,407
EBITDA -3,659 Less Arrow -5,010 More Arrow -4,357
Total assets 3,296 More Arrow 5,161 Less Arrow 2,506
Current assets 3,024 More Arrow 4,959 Less Arrow 2,281
Current liabilities 586 More Arrow 592 Less Arrow 450
Equity capital 2,710 More Arrow 4,569 Less Arrow 2,056
- share capital 230 More Arrow 2,684 Less Arrow 1,762
Employees (average) 5 Equal arrow 5 Less Arrow 4

Financial ratios

Fiscal year 2022/12 2021/12 2020/12
Solvency 82.2% More Arrow 88.5% Less Arrow 82.0%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -111.0% More Arrow -95.3% Less Arrow -173.9%
Current ratio 516.0% More Arrow 837.7% Less Arrow 506.9%
Return on equity (ROE) -135.1% More Arrow -111.6% Less Arrow -214.3%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 More Arrow 1 Less Arrow 0
Chg. No. of employees % 0% More Arrow 25% Less Arrow 0%

Total value of public sale

Fiscal year 2022/12 2021/12 2020/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.